Inventor · disambiguated record
Priya S. Kishnani
Also filed as: KISHNANI PRIYA · KISHNANI PRIYA S
12 granted patents·8 pending applications·37 citations·filing 2009–2024
89Inventor score
Top patents by PatentIndex Score
20 records- 0192US11214782B2Method of treating glycogen storage disease type VIUNIV DUKE·Filed 2020·Granted Jan 4, 2022·3 cites·14 claims
- 0291US10869906B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2017·Granted Dec 22, 2020·4 cites·17 claims
- 0389US10647969B2Method of treating glycogen storage disease type IX using acid alpha-glucosidaseUNIV DUKE·Filed 2017·Granted May 12, 2020·3 cites·12 claims
- 0488US12036190B2Methods and compositions for the treatment of cytoplasmic glycogen storage disordersUNIV DUKE·Filed 2021·Granted Jul 16, 2024·1 cites·14 claims
- 0588US9592247B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2014·Granted Mar 14, 2017·9 cites·14 claims
- 0685US10028993B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2017·Granted Jul 24, 2018·4 cites·14 claims
- 0784US2024398729A1Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage DisordersUNIV DUKE·Filed 2024·Application pending·0 cites
- 0883US9850474B2Methods for treating glycogen storage disease type IV usng lysosomal acid alpha-glucosidaseUNIV DUKE·Filed 2015·Granted Dec 26, 2017·3 cites·15 claims
- 0981US8809282B2Method of reducing titers of antibodies specific for a therapeutic agentKISHNANI PRIYA S·Filed 2011·Granted Aug 19, 2014·7 cites·8 claims
- 1080US9050333B2Method of treating glycogen storage disease type III with human acid α-glucosidaseCHEN YUAN-TSONG·Filed 2009·Granted Jun 9, 2015·3 cites·9 claims
- 1174US2022106579A1Method of Treating Glycogen Storage DiseaseUNIV DUKE·Filed 2021·Application pending·0 cites
- 1273US12290549B2Method of reducing titers of antibodies specific for a therapeutic agentUNIV DUKE·Filed 2020·Granted May 6, 2025·0 cites·16 claims
- 1361US12508305B2Compositions and methods for treating and/or preventing glycogen storage disease type IIIUNIV DUKE·Filed 2021·Granted Dec 30, 2025·0 cites·9 claims
- 1457US2025186618A1Compositions and methods for treating and/or preventing glycogen storage diseasesUNIV DUKE·Filed 2021·Application pending·0 cites
- 1554US2023366887A1Methods of detecting and using biomarkers for glycogen storage diseasesUNIV DUKE·Filed 2021·Application pending·0 cites
- 1651US2025319204A1Compositions for and methods of treating and/or preventing glycogen storage disease type vi and type ixUNIV DUKE·Filed 2021·Application pending·0 cites
- 1750US11944628B2Methods for the use of low-dose immune modulators transiently for treating patients undergoing protein replacement therapyUNIV DUKE·Filed 2018·Granted Apr 2, 2024·0 cites·17 claims
- 1848US2020405722A1Methods for the Use of Low-Dose Immune Modulators Transiently for Treating Patients Undergoing Protein Replacement TherapyUNIV DUKE·Filed 2020·Application pending·0 cites
- 1942US2018326021A1Methods and Compositions for the Treatment of Cytoplasmic Glycogen Storage DisordersUNIV DUKE·Filed 2016·Application pending·0 cites
- 2041US2018207193A1Compositions and methods for improving enzyme replacement therapy for lysosomal storage diseasesUNIV DUKE·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →